Total planned funding: $1,540,971,183
Allocations
Countries/Regions
Tanzania | $297,753,650 |
Nigeria | $289,579,203 |
Zambia | $234,506,868 |
Mozambique | $135,494,767 |
Uganda | $103,608,711 |
Zimbabwe | $82,971,651 |
Rwanda | $62,545,474 |
Kenya | $48,499,210 |
Côte d'Ivoire | $47,780,157 |
Haiti | $47,657,466 |
Democratic Republic of the Congo | $33,257,987 |
Ethiopia | $32,067,108 |
Vietnam | $31,456,709 |
Eswatini | $22,551,889 |
Ukraine | $13,844,691 |
Cameroon | $13,418,016 |
South Africa | $10,881,725 |
Namibia | $7,899,988 |
Malawi | $6,376,202 |
Lesotho | $6,243,247 |
South Sudan | $4,486,426 |
Botswana | $2,316,276 |
Burundi | $2,145,493 |
Central America Region | $1,367,580 |
Indonesia | $1,200,316 |
Guyana | $500,000 |
Cambodia | $358,181 |
Ghana | $202,192 |
Organizational Types
Private Contractor | $1,540,971,183 |
Program Areas
Treatment | $1,540,971,183 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,012,112,590 |
HTXS: Treatment: Adult Treatment | $478,614,745 |
PDTX: Treatment: Pediatric Treatment | $50,243,848 |
Top Partner Programs
Chemonics International:
$963,148,932
View countries
Deloitte Consulting Limited:
$30,291,122
View countries